Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Praveg Ltd.
Source DateBoard Meeting DateDetails
22-May-2025 30-May-2025 Final Dividend & Audited Results
21-Apr-2025 23-Apr-2025 Scheme of Arrangement & Inter alia, to consider and approved the Scheme of Amalgamation ( Scheme ) between Eulogia Inn Private Limited (the Transferor Company) with Praveg Limited (the Transferee Company), and their respective shareholders and Creditors, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ( the Act ) and other applicable laws including the rules and regulations which envisages the amalgamation of Eulogia Inn Private Limited into and with Praveg Limited; ( Proposed Transaction ).
03-Feb-2025 11-Feb-2025 Quarterly Results & Employees Stock Option Plan
05-Nov-2024 14-Nov-2024 Quarterly Results
05-Aug-2024 10-Aug-2024 Quarterly Results & the standalone and consolidated unaudited financial results of the Company for the quarter ended June 30, 2024. Further to intimation dated June 26, 2024, relating to Closure of Trading Window, the Trading Window for dealing in securities of the Company shall remain closed till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2024.
21-May-2024 27-May-2024 Final Dividend & Audited Results
01-Apr-2024 04-Apr-2024 Preferential Issue of shares & Inter alia, to consider and approve:- (1) proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a preferential / rights / qualified institutional placement or any other permissible mode / and / or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
05-Feb-2024 13-Feb-2024 Quarterly Results
20-Dec-2023 26-Dec-2023 Preferential Issue of shares & Inter-alia, to discuss, consider and evaluate proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a preferential / rights or any other permissible mode / and / or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
02-Nov-2023 09-Nov-2023 Quarterly Results
07-Aug-2023 14-Aug-2023 Quarterly Results
26-Jun-2023 28-Jun-2023 Preferential Issue of shares & Issue Of Warrants Inter alia, to consider and approve the proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a rights / preferential or any other permissible mode / and/or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
23-May-2023 30-May-2023 Final Dividend & Audited Results
06-Feb-2023 13-Feb-2023 Quarterly Results
10-Jan-2023 13-Jan-2023 Preferential Issue of shares & Issue Of Warrants inter-alia, to discuss, consider and evaluate proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a rights / preferential or any other permissible mode / and/or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Compan
07-Nov-2022 12-Nov-2022 Quarterly Results
25-Oct-2022 28-Oct-2022 Preferential Issue of shares
05-Aug-2022 13-Aug-2022 Quarterly Results
16-May-2022 24-May-2022 Final Dividend & Audited Results
02-Feb-2022 10-Feb-2022 Quarterly Results
Page 1 of 3
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.